Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | -5.62% | -8.70% | -16.17% |
May. 03 | Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise | MT |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Business Summary
Number of employees: 84
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene and Cell Therapies
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +147.52% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +147.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Amanda Moore
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-30 |
Brian Kevany
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Igor Grachev
CTO | Chief Tech/Sci/R&D Officer | 63 | 21-07-31 |
Director/Board Member | 41 | 16-05-02 | |
Greg Gin
IRC | Investor Relations Contact | - | 20-04-30 |
Corporate Officer/Principal | - | - | |
Alison Hardgrove
HRO | Human Resources Officer | - | 22-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Director/Board Member | 41 | 16-05-02 | |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Donald Wuchterl
BRD | Director/Board Member | 54 | 21-04-18 |
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,808,934 | 36,835,286 ( 94.91 %) | 0 | 94.91 % |
Company contact information
Abeona Therapeutics, Inc.
6555 Carnegie Avenue 4th floor
44103, Cleveland
+646 813 4701
http://www.abeonatherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.17% | 115M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ABEO Stock
- Company Abeona Therapeutics Inc.